Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme. (June 2019)

• Record Type: Journal Article
• Authors: Patil, Rameshwar; Galstyan, Anna; Sun, Tao; Shatalova, Ekaterina S.; Butte, Pramod; Mamelak, Adam N.; Carico, Christine; Kittle, David S.; Grodzinski, Zachary B.; Chiechi, Antonella; Ding, Hui; Black, Keith L.; Ljubimova, Julia Y.; Holler, Eggehard
• Is Part Of: Biomaterials. Volume 206(2019)
• Page Start: 146
• Page End: 159
• Publication Date: 2019-06
• Subjects: Brain tumor surgery -- U87 glioblastoma mouse model -- Fluorescent mini nano agent -- Extreme NIR fluorescence -- Tri-leucine peptide -- Precision of tumor resection; Biomedical materials -- Periodicals; Biocompatible Materials -- Periodicals; Biomatériaux -- Périodiques; 610.28
• DOI: 10.1016/j.biomaterials.2019.03.029
• Languages: English
• ISSNs: 0142-9612

Abstract

Abstract: Maximal surgical resection of glioma remains the single most effective treatment. Tools to guide the resection while avoiding removal of normal brain tissues can aid surgeons in achieving optimal results. One strategy to achieve this goal is to rely upon interoperative fluorescence staining of tumor cells in vivo, that can be visualized by the surgeon during resection. Towards this goal we have designed a biodegradable fluorescent mini nano imaging agent (NIA) with high specificity for U87MG glioma cells and previously unmet high light emission. The NIA is the conjugate of polymalic acid (PMLA) with chlorotoxin for tumor targeting, indocyanine green (ICG) for NIR fluorescence and the tri-leucin peptide as fluorescence enhancer. PMLA as a multivalent platform carries several molecules of ICG and the other ligands. The NIA recognizes multiple sites on glioma cell surface, demonstrated by the effects of single and combined competitors. Systemic IV injection into xenogeneic mouse model carrying human U87MG glioblastoma indicated vivid tumor cell binding and internalization of NIA resulting in intensive and long-lasting tumor fluorescence. The NIA is shown to greatly improve tumor removal supporting its utility in clinical applications. Graphical abstract: Image 1